Subscribe To
CGEN / Compugen Ltd. (CGEN) CEO Anat Cohen-Dayag on Q2 2022 Results - Earnings Call Transcript
CGEN News
By Market Watch
October 9, 2023
These Israeli pharmaceutical stocks are down in the wake of Hamas attack
Shares of Israeli pharmaceutical companies took a hit in premarket trades Monday after Hamas' attack on Israel. more_horizontal
By Zacks Investment Research
August 29, 2023
Has Compugen (CGEN) Outpaced Other Medical Stocks This Year?
Here is how Compugen (CGEN) and Corcept Therapeutics (CORT) have performed compared to their sector so far this year. more_horizontal
By Seeking Alpha
May 15, 2023
Compugen Ltd. (CGEN) Q1 2023 Earnings Call Transcript
Compugen Ltd. (NASDAQ:CGEN ) Q1 2023 Earnings Conference Call May 15, 2023 8:30 AM ET Company Participants Yvonne Naughton - Head of Investor Relation more_horizontal
By The Motley Fool
February 28, 2023
Why Compugen Shares Are Up Today
The company released its fourth-quarter and full-year results after the bell Monday. more_horizontal
By Seeking Alpha
February 27, 2023
Compugen Ltd. (CGEN) Q4 2022 Earnings Call Transcript
Compugen Ltd. (NASDAQ:CGEN ) Q4 2022 Earnings Conference Call February 23, 2023 8:30 AM ET Company Participants Yvonne Naughton - Head, IR and Corpora more_horizontal
By PRNewsWire
February 13, 2023
Compugen to Release Fourth Quarter and Full Year 2022 Results on Monday, February 27, 2023
HOLON, Israel , Feb. 13, 2023 /PRNewswire/ -- Compugen Ltd. (NASDAQ: CGEN), a clinical-stage cancer immunotherapy company and a pioneer in computation more_horizontal
By The Motley Fool
February 8, 2023
Why Compugen Stock Got Slammed Today
Clinical-stage biotechs are particularly susceptible to shifts in analyst sentiment. more_horizontal
By The Motley Fool
December 29, 2022
Why Shares of Compugen Rose on Thursday
The clinical-stage biotech retreated a bit from one of its biggest days in a while. more_horizontal